Business

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

inFoods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS)Research Finds Patients Following a Personalized Diet Therapy Created with inFoods® IBS, Experienced Reduced Abdominal Pain and Bloating IRVINE, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global leader in advanced medical diagnostic solutions, is proud to announce that patients with Irritable Bowel Syndrome (IBS) may experience significant relief from abdomina

articleBiomerica, Inc.February 19, 20258/company/biomerica-inc/news/biomerica-infoods-ibs-clinical-trial-131900979
Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

About this update from Biomerica, Inc.

[{"type":"image","alt":"Biomerica, Inc.","displaySize":"","headline":null,"caption":"Biomerica, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":232,"height":39,"url":"https://media.zenfs.com/en/globenewswire.com/af40ff522792b4c3d1be4034218ddeca"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/m66J9gaNGHXIlBdKngBmxQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTcxO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/af40ff522792b4c3d1be4034218ddeca","width":232,"height":39}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"inFoods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS)","length":105,"tagName":"p"}]},{"val":[{"type":"text","content":"Research Finds Patients Following a Personalized Diet Therapy Created with inFoods® IBS, Experienced Reduced Abdominal Pain and Bloating ","length":136,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":241,"olType":false},{"type":"text","content":"IRVINE, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global leader in advanced medical diagnostic solutions, is proud to announce that patients with Irritable Bowel Syndrome (IBS) may experience significant relief from abdominal pain when following a dietary therapy created and guided by the inFoods® IBS blood test. The findings from a clinical trial published in Gastroenterology, demonstrate that participants who adhered to a personalized diet therapy based on the test results experienced greater symptom improvement compared to those following a sham (placebo) elimination diet.","length":616,"tagName":"p"},{"type":"text","content":"The inFoods® IBS test was designed specifically for IBS patients. It identifies individual foods that trigger an elevated (above normal) Immunoglobulin G (IgG) antibody responses—which is a marker of inflammation associated with IBS symptoms. Every food in the inFoods IBS panel is set with a 95% confidence interval cutoff to provide accurate results. No other IBS product has this technology.","length":394,"tagName":"p"},{"type":"text","content":"Irritable bowel syndrome (IBS) affects an estimated 10% to 15% of adults in the United States and is known to significantly reduce quality of life and work productivity. The condition presents a range of symptoms, including abdominal pain and cramps, which can be e...

More updates from Biomerica, Inc.

testinFoodsIBSImmunoglobulin GThe Company